250+ investors that invest in your industry and stage
Get 250+ investors tailored to your startup
  • Invest in your industry and stage
  • Emails & contact info included
  • Excel and CSV export
  • Automatically
Trusted by 3,000+ startups

Top 50 Life Science Angel Investors in Europe in May 2025

A list of 50 angel investors that invest in Life science startups based in Europe. We rank investors based on the number of investments they made in Life science companies from Europe. We update this investor list every month.

Top 50 Life Science Angel Investors in Europe in May 2025

Investor Life Science Europe investments
Jonathan Milner 9
Nadav Rosenberg 4
Stefano Bernardi 3
Andrew Keys 3
Jeff Dean 3
Luc Vauterin 2
Sauli Törmälä 2
Nico Wittenborn 2
Darrin Disley 2
Bradley Horowitz 2
Ed Parkinson 2
Leena Niemistö 2
Albert Wenger 2
Mike Novogratz 2
Carsten Maschmeyer 2
Andrew Nutter 2
Robert Kopple 2
Nicholas Edwards 2
Thor Bjorgolfsson 2
David Helgason 2
Mati Staniszewski 2
Aidan Gomez 2
Mark Evans 2
Jan Hruska 2
Jude Gomila 2
Pierre Drion 2
Holger Hübner 2
Sylvain Zimmer 2
Ian Hogarth 2
John Anthony Knight 1
Barbara Korte-Sturm 1
Inaki Berenguer 1
Bhavik Bajaj 1
Ryan Bethencourt 1
Edward Lando 1
Laura Iris Ferro 1
Annie Vereecken 1
Duncan Grierson 1
Sharaf Yamani 1
Johnathan Matlock 1
Jon Oringer 1
Balaji Srinivasan 1
Nadav Ben-Chanoch 1
Griet Nuytinck 1
Arman Anatürk 1
Nikolaus Sturm 1
Sophia Bendz 1
Milad Alucozai 1
Per Falholt 1
Arturo Elizondo 1
Find investors that fund startups like yours. Automatically.
Our algorithm will find investors that invest in your industry, stage, and geography.
Investor list
Jonathan Milner Angel · Cambridge, Massachusetts, United States · 11 investments in the past 12 months
Having worked in the life sciences industry for over ten years as an academic researcher, Jonathan identified the market opportunity for supplying high quality antibodies to support protein interaction studies and, in 1998, founded Abcam with David Cleevely and Professor Tony Kouzarides. Jonathan is a Non-Executive Director of Horizon DiscoveryGroup plc, The Evolution Education Trust, GeoSpock Ltd and Sydicate Room Group Ltd. He is also Chairman of Axol Bioscience Ltd, PhoreMost Ltd, Repositive Limited, Definigen Limited and Cambridge Allergy Ltd. Jonathan holds an executive director position at Meltwind Limited, being a designated member of Meltwind Advisory LLP. Jonathan is an experienced entrepreneur and investor and is passionate about supporting UK life science and high-tech start-ups. He has provided considerable investment and support to over 30 companies and has assisted three AIM IPOs.
Show more
Investment focus
  • Biotechnology, Health Care, Medical
  • Seed, Series A, Series B
  • United Kingdom, United States, Spain
Portfolio highlights
  • Quibim — Leading radiomics company pioneering quantitative imaging biomarkers and medical applications in precision medicine.
  • 52 North Health — At 52 North we are developing fully-integrated clinical, AI and medical-device based systems.
  • Exciting Instruments — Exciting Instruments Limited is a joint company founded in Sheffield that combines the software prowess of Bulldozer Limited with Dr. Timothy Craggs' knowledge of single molecules. Through the use of cloud connectivity and real-time data visualisation, we are a genuine science and software partnership on a mission to assist you in streamliningthe procedure for creating discoveries in biophysics, life sciences, drug discovery, and medical diagnostics.
Nadav Rosenberg Angel · London, England, United Kingdom
Nadav leads Taboola’s expansion and operations in Europe and Australia.Prior to joining Taboola, Nadav was a member of the founding team of Groupon UK & IR, taking part in building and managing Groupon’s business in the UK.Before joining Groupon, Nadav worked as a strategy consultant with McKinsey & Company in London.Nadav isbased in London and holds an MBA from INSEAD, France.
Show more
Investment focus
  • Biotechnology, Artificial Intelligence, Software
  • Seed, Pre-Seed, Series A
  • United Kingdom, France, Israel
Portfolio highlights
  • thymia — Making mental health as objectively measurable as physical health.
  • Loops — With Loops causal insights you can identify your biggest opportunities to maximize your KPIs... try the Loops way
  • Lindus Health — Lindus Health. From recruitment to delivery, we accelerate clinical trials. Our mission is to make health research accessible for everyone, everywhere.
Stefano Bernardi Angel · San Francisco, California, United States
Stefano Bernardi is the Investment Director, Climate at Fondazione ENEA Tech.
Show more
Investment focus
  • Biotechnology, Software, Artificial Intelligence
  • Seed, Pre-Seed, Funding Round
  • United Kingdom, Italy, France
Portfolio highlights
  • Freatic — Building the monetization layer for your alpha
  • CaSRevolution — A novel disease-modifying approach against neurodegeneration
  • Automated Architecture — A global ecosystem of automated micro-factories, to deliver sustainable, affordable and beautiful architecture to millions of people.
Andrew Keys Angel
Andrew Keys is the Co-Founder and Managing Partner of Andrew Keys. He previously worked for ConsenSys as a Head of Global Business Development. Andrew Keys attended Loyola University Maryland.
Show more
Investment focus
  • Software, Finance, Blockchain
  • Seed, Pre-Seed, Series A
  • United States, India, Norway
Portfolio highlights
  • Stackr Labs — Micro-rollups to scale web3 applications
  • Zivoe Finance — Join Zivoe in disrupting predatory high-interest lending.
  • Ithaca Finance — Ithaca Finance a cross-chain derivatives trading and settlements protocol, is composed of an on-chain settlement layer with an innovative off-chain matching engine.
Jeff Dean Angel · Palo Alto, California, United States · 24 investments in the past 12 months
Jeff Dean is the Chief Scientist of Google DeepMind and Google Research. He joined Google in 1999 and has played a pivotal role in shaping the company’s technical foundations. He currently focuses on advancing AI and deep learning research across Google’s research teams.He co-founded and led the Google Brain team, helping drive innovations indeep learning for speech recognition, computer vision, natural language understanding, and a wide range of predictive applications. Over the years, he has co-designed and implemented several generations of Google's core systems, including its web search infrastructure, crawling and indexing pipelines, and advertising technologies such as AdSense for Content.He is also a key contributor to Google's distributed computing infrastructure, having co-designed and implemented systems like MapReduce, BigTable, Spanner, Protocol Buffers, LevelDB, and TensorFlow—one of the most widely used open-source machine learning platforms.Jeff Dean earned his Ph.D. in Computer Science from the University of Washington in 1996. He is a Fellow of the ACM, a member of the U.S. National Academy of Engineering and the American Academy of Arts and Sciences, and a recipient of the ACM-Infosys Foundation Award in the Computing Sciences and the Mark Weiser Award.
Show more
Investment focus
  • Artificial Intelligence, Information Technology, Biotechnology
  • Seed, Series A, Pre-Seed
  • United States, United Kingdom, Japan
Portfolio highlights
  • Samaya AI — The company specializes in developing AI research agents that streamline knowledge workflows.
  • Akido Labs — At Akido, we collaborate with healthcare, government, and non-profit institutions to implement programs that tackle inequities in public health.
  • Stately Bio — Stately Bio is the trade-off between measuring cells and keeping them alive. Our patented ML technology measures cell identity, behavior, and maturation—all directly from live-cell, label-free imaging.
Luc Vauterin Angel
Luc Vauterin - Board Member @ ONTOFORCE
Show more
Investment focus
  • Life Science, Data Integration, Data Visualization
  • Seed, Series A
  • Belgium
Portfolio highlights
  • ONTOFORCE — ONTOFORCE creates and implements pioneering semantic search technology for information management. Our user-friendly data search platform DISQOVER builds uniquely intelligent links between heterogeneous data sources, allowing everybody to become a data scientist.
Sauli Törmälä Angel · Helsinki, Southern Finland, Finland
Sauli Törmälä is the Board Member, CFO at Promilless Oy. He attended University of Oulu.
Show more
Investment focus
  • Life Science, Biotechnology
  • Seed
  • Finland
Portfolio highlights
  • Finnadvance — Finnadvance is an Organ-On-Chip company developing high throughput biological barriers on chips to mimic human biology such as vascular, lung and the Blood-Brain-Barriers for small molecule, micro-nano-formulation permeability and toxicity testing with in-vivo like dynamic cell cultures.
Nico Wittenborn Angel · New York, New York, United States
Nico Wittenborn is an Investor at Adjacent.
Show more
Investment focus
  • Software, Health Care, Mobile Apps
  • Seed, Series A, Series B
  • United States, Germany, France
Portfolio highlights
  • Captions — Say hello to Captions, the only camera and editing app that automatically transcribes, captions and clips your talking videos for you.
  • Backbone — Backbone is a mobile gaming controller with intuitive controls, clickable thumbsticks & zero latency that works with cloud and remote gaming.
  • Momentum — Finally, a real solution for major gift fundraising. Powered by AI.
Darrin Disley Angel · Cambridge, Cambridgeshire, United Kingdom
Darrin Disley is the CEO, Director & Investor at Mogrify. He attended University of Cambridge.
Show more
Investment focus
  • Biotechnology, Health Care, Big Data
  • Seed, Series A, Funding Round
  • United Kingdom
Portfolio highlights
  • bit.bio — Bit.bio specializes in the fields of coding and biology that determine the identity of every human cell. Their mission is coding cells for health. To do so, we apply the principles of computation to biology. Bit.bio's current focus is to develop a scalable technology platform capable of producing consistent batches of every human cell. Thishas the potential to unlock a new generation of medicine: it will enable research and drug discovery to move on from inappropriate models and work with the cells that actually are affected by the human disease. A scalable platform of consistent cells will also be the basis for a new generation of cell and tissue therapies. To achieve our goals, we have assembled a team of pioneers in stem cells, cellular reprogramming, mathematical modeling, and cell therapy. Collaboration is at the heart of bit.bio. We are empirical, highly ambitious, and driven by a common purpose.
  • Mogrify — Mogrify is pioneering a new class of in vivo reprogramming therapy and transforming the development of ex vivo cell therapy.
  • Desktop Genetics — Desktop Genetics is an international biotechnology company established in 2012 to help researchers discover and treat the root genetic causes of human disease. Today, Desktop Genetics is a recognised leader in genome editing technology, staffed by dedicated team of genome editing experts, bioinformaticians and data scientists, driven by thereal-world impact of CRISPR technology.They have invested four years developing their core technology, DESKGEN AI, trained on the largest database of genome editing data in the world. DESKGEN AI powers their flagship DESKGEN CRISPR Library product range, which enables the work of their pharma, biotech and academic customers working in drug discovery and functional genomics. Desktop Genetics' tools and technologies are used by over 1800 organisations all over the world, and their projects contribute directly to several key partnerships to bring CRISPR into the clinic. The company has received awards from Fast Company, Kairos 50 and SxSW Interactive.
Bradley Horowitz Angel · Palo Alto, California, United States · 2 investments in the past 12 months
Bradley Horowitz is an Advisor and Vice President of Product Management at Google. Most recently he helped create Area 120, Google's incubator for internally-sourced innovation. He's led a large number of products, programs and initiatives at Google - including Google for Startups, Google Photos, Gmail, Google Voice, blogger, and GoogleNews.Before joining Google in February 2008, Horowitz was Yahoo's vice president of Advanced Development where he drove the acquisitions of Flickr and MyBlogLog, launched the Brickhouse incubator and developed new products like Yahoo! Pipes. Additionally, he was responsible for the company's initiative to open up its platform which included overseeing the Yahoo Developer Network (YDN).Previously, he was co-founder and CTO of Virage, where he oversaw the technical direction of the company from its founding through its IPO and eventual acquisition by Autonomy.Horowitz was a PhD candidate at the MIT Media Lab. While at the Media Lab, he worked on a number of topics related to computer vision, graphics and image processing, which resulted in a patented new technique for the recovery of structure, motion and camera parameters from video sequences.Horowitz holds an MS in Media Science from MIT and a BS in Computer Science from the University of Michigan.
Show more
Investment focus
  • Software, Information Technology, Health Care
  • Seed, Series A, Series B
  • United States, United Kingdom, Germany
Portfolio highlights
  • Catena Labs — Catena is a product studio where we transform complex computing advancements into accessible, practical tools for users and developers. Leveraging AI and web3 technology our aim is to turn innovative ideas into real-world applications that are easy to use.
  • Odyssey — We're pioneering world models, the next frontier of artificial intelligence.
  • Overture Life — We are making In Vitro Fertilization (IVF) more accessible than ever before while improving success rates. An embryology lab in a box.
Ed Parkinson Angel
Ed Parkinson
Show more
Investment focus
  • Software, Health Care, Life Science
  • Seed
  • United Kingdom
Portfolio highlights
  • Antiverse — Designing biologics for 100 challenging targets
Leena Niemistö Angel · Helsinki, Southern Finland, Finland
Leena Niemistö
Show more
Investment focus
  • Health Care, Software, E-Commerce
  • Seed, Funding Round, Pre-Seed
  • Finland, United States
Portfolio highlights
  • Rens Original — RENS Original is the World's First Sneaker made from recycled coffee and plastic. We know you've been drinking it, now it is time to wear it.
  • Maire — Maire - AI co-pilot for industry leading B2C E-commerce brands. From Industry Trends to Market Research and Search Intent Analysis
  • Finnadvance — Finnadvance is an Organ-On-Chip company developing high throughput biological barriers on chips to mimic human biology such as vascular, lung and the Blood-Brain-Barriers for small molecule, micro-nano-formulation permeability and toxicity testing with in-vivo like dynamic cell cultures.
Albert Wenger Angel · New York, New York, United States
Albert Wenger is a managing partner at Union Square Ventures. Before joining USV, Albert was the president of del.icio.us through the company’s sale to Yahoo and an angel investor (Etsy, Tumblr). He previously founded or co-founded several companies, including a management consulting firm and an early hosted data analytics company. Albert graduatedfrom Harvard College in economics and computer science and holds a Ph.D. in Information Technology from MIT.
Show more
Investment focus
  • Software, Analytics, Manufacturing
  • Series A, Series B, Seed
  • United States, Germany, Egypt
Portfolio highlights
  • Brale — Combining the best of CeFi & DeFi.
  • Terra.do — Learn about climate change and start working on climate change solutions today with the Terra.do community.
  • Unearthly Materials — Unearthly Materials is a transformative materials company focused on delivering practical room-temperature superconductors and powering the century of superconductivity.
Mike Novogratz Angel · New York, New York, United States
Michael E. Novogratz is the CEO of Galaxy Investment Partners. He was formerly a principal and a member of the board of directors of Fortress Investment Group LLC and Chief Investment Officer of the Fortress Macro Fund. Mr. Novogratz joined Fortress in 2002 after spending 11 years at Goldman Sachs, where he was elected partner in 1998. Mr.Novogratz founded and serves as the Chairman of the Board for Beat the Streets, a non-profit organization which builds wrestling programs in New York City public schools and is also the Honorary Chairman of USA Wrestling Foundation. Mr. Novogratz is Chairman of The Friends of the Hudson River Park. He also serves on the board of the Acumen Fund, NYU Langone Medical Center, Princeton Varsity Club and The Jazz Foundation of America. Mr. Novogratz received an AB from Princeton University in Economics, and served as a helicopter pilot in the US Army.
Show more
Investment focus
  • Blockchain, Cryptocurrency, FinTech
  • Seed, Funding Round, Series B
  • United States, India, Germany
Portfolio highlights
  • Portal — The only custody-less interoperability protocol for Bitcoin. Swap native BTC, Ordinals, Runes with L2s and L1s
  • Verandah — Verandah is story based conscious luxury resort brand retailing amongst the top 100 in the global luxury resort wear space with design roots strongly based in India. Verandah also has a line of 100% Italian made sustainable swimwear to compliment the season-less ready to wear line.
  • Cambrian Biopharma — Cambrian is developing a raft of new companies and therapies to extend healthy lifespan, bringing proven scientific and organizational expertise to exceptional research teams worldwide.
Carsten Maschmeyer Angel · Hanover, Niedersachsen, Germany
Carsten Maschmeyer is a successful entrepreneur, consultant and financial investor. He was born on May 8, 1959 in Bremen and grew up in Hildesheim. After his graduation in 1978 Maschmeyer completed military service before he began to study medicine in Hannover. To finance his studies, he worked part-time in sales of investment advice to it in 1982completely dedicated financial advice. More about Carsten Masch Meyers consultant. In 1988 Carsten Maschmeyer to AWD financial group, which was successfully launched on the stock market in 2000 and rise to the MDAX and expanded in 11 countries. Was sold in 2007 Carsten Maschmeyer all his shares in the company at the insurance group Swiss Life, who renamed the AWD in AWD Holding. Maschmeyer has today different occupational focuses, inter alia, as entrepreneur, investor and consultant. His experience Carsten Maschmeyer a sought-after speaker on the subject of success. Motivated by the desire expressed by many listeners to learn more about his secret of success, Carsten Maschmeyer published in the spring of 2012 his book "Self Made - performance live richly". In it he describes the basis of his own exciting path and the celebrities strategies for professional, financial and personal success.
Show more
Investment focus
  • Software, Information Technology, Artificial Intelligence
  • Seed, Angel, Series A
  • Germany, Austria, Switzerland
Portfolio highlights
  • Zeedz — Gaming for a green future. Zeedz is a monster collectible game that targets real-world climate change. Discover a world of plantified magic, made in Berlin.
  • theblood — We are giving back self-determination, control and specific health conditions to our users through a non-invasive menstrual blood test
  • JobSwop.io — JobSwop.io is the employment software that allows you to find available positions but also filled ones for people looking to move jobs. The features of this app are Salary information, a Watch list, Area search, Integrated chat, Up to three Job profiles in one account, Document management.
Andrew Nutter Angel · Paris, Ile-de-France, France
Andrew Nutter is a Co-Founder at Gama. He attended Stanford University.
Show more
Investment focus
  • Software, SaaS, Biotechnology
  • Seed, Pre-Seed, Funding Round
  • France, United Kingdom, United States
Portfolio highlights
  • Yavin — Yavin provides modern point-of-sale solutions for European merchants
  • Gama — Thanks to cheap, reliable and scalable solar sails, we are redefining deep space access.
  • EV Biotech — We design and optimise your precision fermentation strains and processes, tailored to your success.
Robert Kopple Angel · Los Angeles, California, United States
Robert Kopple
Show more
Investment focus
  • FinTech, Finance, Life Science
  • Funding Round, Convertible Note
  • United States, United Kingdom
Portfolio highlights
  • Tradier — Tradier is a financial services cloud provider that offers a groundbreaking solution to serve platform providers, developers and investors. The Tradier solution features an innovative set of fully hosted APIs, modules, and "out of the box" tools that are leveraged by a growing list of providers.
  • ILC Therapeutics — ILC Therapeutics Ltd is an early-stage biotechnology company focused on modulating the Innate Immune System through the development of novel peptide therapeutics for the treatment of Covid-19, Cancer, Atopic Dermatitis, and Psoriasis.
Nicholas Edwards Angel · Oxford, Oxfordshire, United Kingdom
Nick serves as the Chairman of Prescient’s Board of Directors. He holds a degree in physiological sciences from The Queen’s College, University of Oxford, and completed his training in clinical medicine (BM, BCh) at Green College (now Green Templeton College), University of Oxford. Nick practiced in the areas of cardiology and general surgerybefore joining Andersen Consulting (now known as Accenture), eventually becoming the global leader of Accenture’s pharmaceutical R&D business during his 18-year tenure. In 2005, he founded Kinapse to provide consulting and outsourcing services to the pharmaceutical industry. Nick served as Kinapse’s Chairman until the company was sold to HgCapital in early 2016.
Show more
Investment focus
  • Medical, Health Care, Life Science
  • Seed, Funding Round
  • United Kingdom
Portfolio highlights
  • Oxford Medical Products — Oxford Medical Products is a UK-based biotechnology start-up revolutionising the weight-loss treatment space with its hydrogel-based technology.
Thor Bjorgolfsson Angel · London, England, United Kingdom
Thor Bjorgolfsson - Entrepreneur, Businessman and Adventure Capitalist Thor Bjorgolfsson, Iceland’s first and only current billionaire, is an investor and business innovator who is not afraid of risk. He has been an entrepreneur since childhood, making his first deal at the age of 10, when he purchased a stack of vintage Marvel comics withborrowed money.In 2004, he founded Novator Partners, an alternative investment firm. He has strategically developed the company to allow it to maintain maximum flexibility as well as to facilitate investments in both strategic (buy and hold) and financial (buy and exit) opportunities.With Novator, Thor leverages private equity as well as macro investments and manages assets across a variety of sectors and geographic locations. He is an active investor in emerging economies including Central and Eastern Europe as well as Latin America.Novator Partners has been a major player in telecom businesses. Thor is a stakeholder in a Polish telecom company called Play, which went public in 2017. In addition, he holds shares in WOM, a Chilean telecommunications firm.Bjorgolfsson’s first fortune was made in post-soviet Russia. At a time when others perceived Russia to be tumultuous, he saw an underserved market that presented an exciting opportunity to invest in great ideas and businesses. He co-founded and developed Bravo Brewery, which produced beer and alcopops. Bravo became one of Russia’s premier brewing companies, particularly through its popular Botchkarov beer brand. Thor sold the business in 2002 to Heineken for $100 million.With the sale of Bravo, he was able to diversify his holdings by reinvesting in new ventures, focusing on telecommunications, pharmaceuticals, and banks. In a few years, he was able to turn that $100 million into a net worth of over $2.1 billion.A year after being featured on the 2007 cover of Forbes Magazine, Iceland went nearly bankrupt overnight and Thor found himself at the epicenter of the financial crisis. As a major shareholder in Landsbanki with personal guarantees of 350m euro, he refused to declare bankruptcy and eventually succeeded in paying off all of it. He then went on to invest in new businesses, re-establishing himself and being featured on the Forbes list of billionaires once again.During this time of rejuvenation, he wrote Billions to Bust and Back: How I Made, Lost and Rebuilt a Fortune, And What I Learned on the Way (2014). In the book, he shares his perspective of what it was like to be at the center of the storm and how he made it back to financial success. He proposes that the greatest strength an entrepreneur can possess is a positive attitude.The 52-year-old Thor was educated in the United States where he earned a Bachelor of Science degree from New York University. In 2005, he was honored as a Young Global Leader by the World Economic Forum. In spite of his intense schedule, Thor enjoys sharing his experience and business insight, making him a sought-after speaker. A multilingual Icelandic citizen, Thor spends most of his time in London, living with his wife and three children. Thor's personal passion is his collection of six motorcycles, which he rides whenever time permits.
Show more
Investment focus
  • Big Data, TV, TV Production
  • Seed, Series A, Series C
  • United Kingdom, Germany
Portfolio highlights
  • Olvin — Olvin helps reactive real-world businesses get ahead of the curve and become proactive through the use of its AI powered, predictive analytics platform. Harnessing billions of real world data points, from events and precise location, through to weather and points of interest, Olvin's advanced neural network identifies patterns. Through theuse of both probabilistic and deterministic scoring, Olvin's AI provides actionable insights to brands, retailers and businesses to give them an unparalleled opportunity to delight their customers, identify opportunities and get ahead of potential threats.
  • DNEG — We are DNEG, one of the world's leading visual effects and animation studios for feature film and television, honoured with the Academy Award six times
  • atai Life Sciences — We are a clinical-stage biopharmaceutical company developing new mental health treatments to transform patient outcomes.
David Helgason Angel · Copenhagen, Hovedstaden, Denmark
David is a technologist, the founder of Unity Technologies, non-exec director to others, and a restless entrepreneur with a passion for creating feedback loops between innovation and teams and products, applying new and old business models to changing industries, and pushing people to do the very best they can do.David's background is inprogramming, an assortment of university dabbling, creating companies, and helping entrepreneurs. He served as CEO of Unity Technologies since co-founding it in 2003 and until October 2014, with an unflinching vision to democratize game development, and to develop technology and business models for the next phase of the games industry. David Helgason attended the University of Copenhagen.
Show more
Investment focus
  • Software, Gaming, Information Technology
  • Seed, Funding Round, Pre-Seed
  • United States, Denmark, Finland
Portfolio highlights
  • Isometric — Isometric is a carbon removal standard and registry.
  • Slope — We handle the lending, underwriting, debt collection and fully pay out to you immediately once the product or service ships.
  • Rocky Road — At Rocky Road, we are redefining social gaming with our social gaming network. We are hiring!
Mati Staniszewski Angel · London, England, United Kingdom · 2 investments in the past 12 months
Mati Staniszewski is the Co-Founder of ElevenLabs.
Show more
Investment focus
  • Software, Information Technology, Artificial Intelligence
  • Pre-Seed
  • United States
Portfolio highlights
  • Latent Labs — Latent Labs is making biology programmable to transform health and sustainability for the benefit of all.We are a frontier AI lab building foundational models that capture the fundamentals of biology. We empower partners with breakthrough generative AI to gain unprecedented control over molecular biology, creating new antibodies, optimizingexisting enzymes, and advancing genetic engineering.Contact us to work with us today.
  • Zeta Labs — Revolutionize daily tasks with our AI assistant. Not just a chatbot - it chats, understands, and performs. Free yourself to focus on meaningful things.
Aidan Gomez Angel · Oxford, Arkansas, United States · 2 investments in the past 12 months
Aidan Gomez is a Co-founder & CEO of Cohere. He attended University of Oxford.
Show more
Investment focus
  • Artificial Intelligence, Software, Information Technology
  • Seed, Pre-Seed
  • United States
Portfolio highlights
  • DatologyAI — DatologyAI optimize training efficiency, maximize performance and reduce compute costs with expert curation.
  • Latent Labs — Latent Labs is making biology programmable to transform health and sustainability for the benefit of all.We are a frontier AI lab building foundational models that capture the fundamentals of biology. We empower partners with breakthrough generative AI to gain unprecedented control over molecular biology, creating new antibodies, optimizingexisting enzymes, and advancing genetic engineering.Contact us to work with us today.
  • Helical — The full power of DNA & (m)RNA Bio Foundation Models in one open-core platform. Accelerate Drug Discovery with AI.
Mark Evans Angel · London, England, United Kingdom
Mark is currently a Founding Partner and LP and Investment Committee member at Kindred Capital, a European Seed-Stage Venture fund, based in London. He was a General Partner at Balderton Capital/ Benchmark Europe from 2002 through 2015, and an EIR at Benchmark Capital in 1999/2000.He spent the prior 15 years @ Goldman Sachs, where hewas a General Partner and Management Committee member. He studied Economics at both University of Oxford and Queen's University in Canada.
Show more
Investment focus
  • Software, E-Commerce, Health Care
  • Series A, Seed, Funding Round
  • United Kingdom, United States, The Netherlands
Portfolio highlights
  • ONI — Where are you in your super-resolution journey? ONI is here to support you along your super-resolution journey Answer a few simple questions to discover key resources that can help you make the most of single-molecule imaging technology across a wide range of applications Products Gallery FAQs Subscribe to our mailing list
  • Ufonia — Ufonia is replacing routine patient healthcare interactions with next-generation automated phone calls.
  • Arctoris — Arctoris is a platform company headquartered in Oxford, with its US operations based in Boston and its APAC operations based in Singapore. Arctoris developed and operates a unique drug discovery platform powered by advanced robotics and data science combined with an experienced team of biotech & pharma veterans. Arctoris actively pursuesseveral drug discovery programs in oncology and neuro, while also providing access to its platform to select biotech and pharma partners. Arctoris' approach of data-driven drug discovery leads to higher chance of success, and an accelerated progression of programs towards the clinic.
Jan Hruska Angel
Jan Hruska
Show more
Investment focus
  • Medical, Health Care, Life Science
  • Seed, Funding Round
  • United Kingdom
Portfolio highlights
  • Oxford Medical Products — Oxford Medical Products is a UK-based biotechnology start-up revolutionising the weight-loss treatment space with its hydrogel-based technology.
Jude Gomila Angel · San Francisco, California, United States
Jude Gomila is currently CEO and Founder of the startup Golden.
Show more
Investment focus
  • Software, Biotechnology, Information Technology
  • Seed, Pre-Seed, Angel
  • United States, United Kingdom, Canada
Portfolio highlights
  • Parcha AI — Parcha is an AI-powered enterprise software that enables businesses to automate their scale compliance and operations.
  • HockeyStack — HockeyStack enables marketing teams to drive pipeline efficiently and sales teams to close deals faster with modern attribution, holistic buyer journeys, and account insights.
  • Farmako — Install Farmako app, get a free health ID and get all your medical records safe and secure in one place!
Pierre Drion Angel · Brussels, Brussels Hoofdstedelijk Gewest, Belgium
Pierre Drion - CEO @ Petercam
Show more
Investment focus
  • Biotechnology, Health Care, Life Science
  • Series A, Series B, Funding Round
  • Belgium
Portfolio highlights
  • A-Mansia Biotech — A-Mansia Biotech is a developer of products based on the properties of the Akkermansia muciniphila (A. muciniphila) bacterium. The company's nutritional supplement based on a gut bacterium called Akkermansia, the population of microorganisms housed in the gastrointestinal tract. A. muciniphila is located in the mucus layer covering theintestinal epithelium, which allows the bacterium to establish a close cross-talk with the host.
  • Novadip Biosciences — Novadip Biosciences, an advanced biopharmaceutical company focused on new generation of therapies from adipose stem cells adapted to hard and soft tissues reconstruction.
  • Santero Therapeutics — This is the homepage of the website
Holger Hübner Angel · Hamburg, Hamburg, Germany
Holger Hübner
Show more
Investment focus
  • B2B, SaaS, Audio
  • Seed, Pre-Seed
  • Germany
Portfolio highlights
  • musicube — Good music deserves to be found. That is why musicube develops revolutionary music search technology. Music streaming services and other companies can forward any user request to musicube and get back high quality data in real time (e.g. to return playlists etc.).
  • RetroBrain R&D GmbH — Memore gamifies proven dementia therapies into a gesture controlled medical video game. It incorporates and gamifies proven therapies, delaying the effects of dementia and mild cognitive impairment, enabling elderly people without prior gaming experience to utilize the gaming suite easily.Memore works both therapeutically and preventatively withnursing rehabilitation. It was founded in 2014 and is based in Hamburg, Germany.
  • HorseAnalytics — HorseAnalytics empowers horse enthusiasts to monitor and improve health and training of horses by applying reliable technologies from health and sports supervision and combining constant and real-time scientific analytics.
Sylvain Zimmer Angel · Paris, Ile-de-France, France
Sylvain is a French software developer turned entrepreneur, conference organizer and angel investor.
Show more
Investment focus
  • Software, Financial Services, SaaS
  • Seed, Pre-Seed, Angel
  • France, United States, United Kingdom
Portfolio highlights
  • GOURMEY — We create sustainable cultivated meat delights for an uncompromising and conscious generation.
  • Waldo — The codeless way to quickly build a comprehensive test suite for teams who don't compromise on speed and quality.
  • TOTEM — A Totem is a place of sharing and conviviality in your office. This is an opportunity for your colleagues to get to know each other better, celebrate victories and defeats together, and build a solid culture.
Ian Hogarth Angel · London, England, United Kingdom
Ian got a master's in machine learning at Cambridge and loves dystopian robot takeover narratives. Seven years ago, Ian realized being a choirboy came with no street cred, so he started DJing hip-hop, funk, drum & bass, and grime. Ian quit his job at Bain & Company, Singapore to start Songkick.
Show more
Investment focus
  • Software, E-Commerce, Internet
  • Seed, Pre-Seed, Series A
  • United Kingdom, United States, Germany
Portfolio highlights
  • Claimer — Claimer is a self-service application that gets credit claims done easily of money spent on research and development. Its platform empowers company owners and advisors to prepare their claims, without any specialist knowledge, no matter how big or small the claim. It also prepares and submits the amended tax return for free.Claimer was founded in2019 by Adam McCann and is headquartered in Croydon, United Kingdom.
  • Unitary — We detect harmful content with context-aware AI to keep brands and platforms safe online.
  • Fabric — One home for your digital world. Your second brain. A file explorer and workspace for the internet age. All your drives, clouds, notes, screenshots, links, and files in one calm, minimal app. No organizing required. Never forget anything again.
John Anthony Knight Angel
John Anthony Knight
Show more
Investment focus
  • Software, Life Science, Biotechnology
  • Seed
  • United Kingdom
Portfolio highlights
  • Synthace — The Synthace Experiment Platform lets you design powerful experiments, run them in your lab, & gather automatically structured datasets. No code necessary.
Barbara Korte-Sturm Angel
Barbara Korte-Sturm
Show more
Investment focus
  • Life Science, Biotechnology
  • Seed
  • Germany
Portfolio highlights
  • DNTOX — We are building up a bioanalytical testing laboratory for animal-free screening of chemicals, regarding their potential to disturb brain development and cause developmental neurotoxicity (DNT). Our in vitro testing battery is based on human cell models and enables chemical screening in a high-content and medium-throughput fashion. Furthermore, itis supported by an in-house developed software, using artifical intelligence. We support our customers during the identification of safe lead structures during substance development, as well as the safety assessment during approval and re-approval processes of chemicals. With our innovation, we want to realize our company vision: Safe chemicals without animal experiments!
Inaki Berenguer Angel · New York, New York, United States
Inaki Berenguer is the President and Co-founder at iPronics Programmable Photonics.
Show more
Investment focus
  • E-Commerce, FinTech, Software
  • Seed, Angel, Pre-Seed
  • Spain, United States, United Kingdom
Portfolio highlights
  • Goin — Goin is a mobile application to save money easily and take advantage of it without knowing how to invest, through Machine Learning algorithms that allow you to accumulate the user's money through small daily gestures. he three Spanish founders, David, Carlos and Gabriel, were looking for a way to optimize their own money, and decided toconduct an experiment by exchanging their debit cards and thus saving 62% during those two months of rehearsal. This is how Goin emerged, which aims to meet the needs of 100% of Millennials, of which 83% confess that they do not know how to save, making available an easy-to-use tool that enhances their finances and lifestyle. On the one hand, the Barcelona startup allows the user to add money automatically and multiply it without having previous knowledge of investment. Goin uses a simple system that first asks to know the user through questions about their habits and, in this way, they are offered automatic systems and methods of saving. Once the user adds money to the app, they can transfer part or all of it to investment, or to their bank account. Its Smart Saving technology manages to accumulate money with small, everyday gestures, such as rounding a payment.
  • Bankflip — Permissioned data technology to collect and process your customers' income, tax, employment & other relevant data & documents in real-time
  • Mable (Neurolytic Healthcare) — Neurolytic Healthcare provides personalized medicine for neurological conditions. Neurolytic Healthcare collects and extracts insights from a combination of genetic and biomarker data to enhance diagnosis and help clinicians decide on optimal treatment strategies for neurological conditions.The company delivers digitally and genomically-drivenmedical devices to improve the current treatment of migraine and other neurological disorders, including a diagnostic support tool, pharmacogenetic test, and a mobile app for migraine event prediction.
Bhavik Bajaj Angel
Bhavik Bajaj
Show more
Investment focus
  • Information Technology, Software, FinTech
  • Pre-Seed, Seed, Angel
  • United States, United Kingdom, Switzerland
Portfolio highlights
Ryan Bethencourt Angel · San Francisco, California, United States
Ryan is a co-founder and CEO at Wild Earth and a co-founder and Partner at Sustainable Food Ventures, bringing years of experience in leading, building and advising high-growth food and biotechnology companies. Ryan is a biotech entrepreneur, investor, and one of the founders of the biohacker movement. He’s a co-founder and former Program Directorat IndieBio and has invested in over 130 early stage biotech startups and served as the head of life sciences at the XPRIZE Foundation. As an ethical vegan, Ryan is passionate about the future of biology as a technology, applied across all industries to solve some of humanity’s most intractable problems. Ryan fosters dogs for Rocket Dog Rescue and is passionate about mindfulness, meditation, and mentoring. His work at the interface of science, food, and business has been covered by many major publications.
Show more
Investment focus
  • Biotechnology, Food Processing, Food and Beverage
  • Pre-Seed, Seed, Angel
  • United States, Chile, India
Portfolio highlights
  • WTH Foods — WTH Foods is a plant-based alternative protein company based in Manila, Philippines. Using local and sustainable ingredients, we create plant-based versions of processed meat products that Southeast Asian love
  • Sobo Foods — Sobo Foods is a plant based comfort food provider.
  • Libre Foods — MEAT, BUT MAKE IT MUSHROOMS. GET READY TO TASTE THE POWER OF FUNGI
Edward Lando Angel · San Francisco, California, United States · 5 investments in the past 12 months
Edward Lando is the Founder of Pareto Holdings. He previously worked at Horizons School of Technology as a Co-Founder. Edward Lando attended the Wharton School.
Show more
Investment focus
  • Software, Information Technology, Health Care
  • Seed, Pre-Seed, Funding Round
  • United States, United Kingdom, France
Portfolio highlights
  • SiPay — Sipay is a next-generation financial technology company offering a comprehensive all-in-one financial services platform. It enables B2B, B2C, and Sipay as a Service (Embedded Finance) customers to address all their banking and financial needs without requiring any other partners.
  • Syntetica — Syntetica is a nylon recycling startup that addresses pollution in the fashion industry by transforming discarded nylon products into high-quality, reusable materials. Their innovative processes help reduce waste, conserve resources, and promote sustainability within the fashion sector.
  • Unicorn Auctions — Unicorn Auctions offers rare spirits auctions to buyers, sellers, and collectors. They provide ios and android apps in addition to their web bidding platform for digital auctions. To ensure examination of every asset listed, they must take physical possession of their items.
Laura Iris Ferro Angel · Milan, Lombardia, Italy
Laura Iris Ferro
Show more
Investment focus
  • Health Care, Biotechnology, Medical Device
  • Pre-Seed, Funding Round
  • Italy
Portfolio highlights
  • Newronika — Newronika restores brain and body functions with innovative technologies. We translate our deep knowledge on biosignal decoding into clinical practice, with the aim of improving treatments, health, and wellness. With our revolutionary brain devices, the patient receives the right stimulation at the right moment, thus becoming able to perform normaldaily activities and improve quality of life. Newronika is the spin-off company of two leading research institutions in Italy, the Fondazione IRCCS Ca' Granda Ospedale Maggiore Policlinico Hospital and the University of Milan. ​ Newronika comprises a multidisciplinary team formed from Neuroscience research groups and involves scientists with expertise in neurophysiology, neurology, biomedical engineering, neuropsychology, bioinformatics, and biotechnologies.
  • Bio4Dreams — Il primo incubatore italiano certificato di startup innovative in fase very early stage, a capitale totalmente privato, dedicato alle Scienze della Vita.
Annie Vereecken Angel
Annie Vereecken
Show more
Investment focus
  • Biotechnology, Medical, Hospital
  • Seed, Series A, Funding Round
  • Belgium
Portfolio highlights
  • Ziphius — Ziphius Vaccines is a biopharmaceutical company dedicated to developing next-generation vaccines for the prevention of infectious diseases.
  • Sensolus — Sensolus provides care-free tracking of your valuable non-powered assets directly from the cloud.Sensolus offers turnkey solutions for wireless, low-power context-aware sensing. Sensolus developed a personal product line of low-power tracker systems called STICKNTRACK.Sensolus is built upon many years of expertise in low-power networks,wireless sensor design, cloud-based sensor management, analytics, and applications.
  • Allegro Biotech — Allegro has developed the world’s-first custom-tailored, durable, biocompatible, anisotropic, regenerative meniscus cartilage, providing immediate support while also leverage the body’s own healing potential to regenerate human cartilage (proliferation and differentiation of fibrochondrocyte cells).
Duncan Grierson Angel
Duncan Grierson
Show more
Investment focus
  • Water, Medical, CleanTech
  • Seed, Series A
  • United Kingdom
Portfolio highlights
  • Puraffinity — Puraffinity develops targeted materials for water treatment, focused on forever chemicals called PFAS. Our strategic intent is to provide 1 billion people with PFAS safe water by 2030
  • Moixa Technology — Moixa Technology develops the Maslow intelligent energy storage solution, enabling homes to store energy and benefit from revenue streams generated by trading energy through GridShare, an SaaS platform that aggregates energy from groups of Maslow energy storage systems. . The company develops smart DC technologies to power DC lighting, computing,electronics from grid-shifted storage or local PV from smart DC hubs, variable DC networks and sockets. The technology and IPR reduces grid peak by shifting DC device load and powering DC devices efficiently without inverters or AC/DC adaptors, together with providing smart control and energy management. The technology aims to address the 1 trillion kwh + lost annually in power conversion, and the significant growing DC demand in homes, offices from ICT, LED lighting and the rise in internet connected devices.
Sharaf Yamani Angel · London, England, United Kingdom
Sharaf Yamani - Managing Director @ Windlesham Advisors
Show more
Investment focus
  • Biotechnology, Software, Life Science
  • Seed
  • India, United Kingdom
Portfolio highlights
  • CyGenica — CyGenica uses a non-viral, non-toxic platform to develop in vitro and in vivo delivery solutions for drugs, gene editing components, and antibiotics.
  • Synthace — The Synthace Experiment Platform lets you design powerful experiments, run them in your lab, & gather automatically structured datasets. No code necessary.
Johnathan Matlock Angel · Bedford, Bedfordshire, United Kingdom
Johnathan Matlock is Co-Founder Science Angel Syndicate.
Show more
Investment focus
  • Biotechnology, Medical, Health Care
  • Seed, Pre-Seed
  • United Kingdom
Portfolio highlights
  • Zentraxa — NATURE ENGINEERED FOR PURPOSE Through millions of years of evolution, nature has found solutions to the most difficult problems. Inspired by the diversity of nature, we precision engineer bespoke biomaterials to meet the toughest challenges across
  • EnsiliTech — EnsiliTech is a biotechnology start-up developing ensilication, a platform technology, to remove the need for refrigeration when transporting and storing vaccines and biologicals
  • Halo Therapeutics — Halo Therapeutics is based in England. Develops safe pan coronavirus antiviral drugs for Covid-19 that can be administered by patients.
Jon Oringer Angel · Miami, Florida, United States
Jon Oringer is the founder and chairman of Shutterstock.
Show more
Investment focus
  • Software, Information Technology, E-Commerce
  • Seed, Pre-Seed, Funding Round
  • United States, France, United Kingdom
Portfolio highlights
  • SLUSHY — Slushy is the ultimate adult social platform for new creators. Post content, grow your following, and monetize your profile all in one place. Reach new fans on day one with instant approvals and payouts on demand. Sign up and start earning today!
  • Skedway — The optimization hub for the Modern Enterprise - Visualize, integrate and manage every shared company asset in one place.
  • Unsloth AI — Open-source LLM fine-tuning for Llama 4, Phi 4, Gemma 3, Mistral and more! Beginner friendly. Get faster with Unsloth.
Balaji Srinivasan Angel · San Francisco Bay Area, California, United States · 23 investments in the past 12 months
Balaji S. Srinivasan is the Co-Founder and Board Member of Coin Center. He was the CTO of Coinbase and cofounder of Counsyl, Earn, Teleport, and Coin Center. He was previously CEO at Earn.com, which was recently sold to Coinbase. Prior to taking the CEO role at Earn.com, Dr. Srinivasan was a General Partner at Andreessen Horowitz. Prior to joininga16z, he was the co-founder and CTO of Founders Fund-backed Counsyl, where he won the Wall Street Journal Innovation Award for Medicine and was named to the MIT TR35. Dr. Srinivasan holds a BS, MS, and PhD in Electrical Engineering and an MS in Chemical Engineering from Stanford University. He also teaches the occasional class at Stanford, including an online MOOC in 2013 which reached 250,000+ students worldwide.
Show more
Investment focus
  • Blockchain, Cryptocurrency, Software
  • Seed, Pre-Seed, Series A
  • United States, India, Singapore
Portfolio highlights
  • ZAR — ZAR establishes a connection between cash-based economies and the web3 framework, facilitating adoption of stablecoins.
  • Kindly MD — Kindly MD is a healthcare services and technology company that offers solutions for sleep support, pain treatment, and medication management through advanced data analytics. The company integrates mental health services, traditional medication, and plant-based alternatives to provide comprehensive, whole-person treatment. Dedicated to promoting abrighter, healthier future, Kindly MD delivers personalized care that addresses the unique needs of each patient.
  • Catena Labs — Catena is a product studio where we transform complex computing advancements into accessible, practical tools for users and developers. Leveraging AI and web3 technology our aim is to turn innovative ideas into real-world applications that are easy to use.
Nadav Ben-Chanoch Angel · Miami, Florida, United States · 12 investments in the past 12 months
Nadav Ben-Chanoch - Partner @ Pareto Holdings
Show more
Investment focus
  • Software, Information Technology, Health Care
  • Seed, Pre-Seed, Funding Round
  • United States, United Kingdom, France
Portfolio highlights
  • Swaap — We build the market-neutral AMM protocol.
  • micro1 — We help companies hire and manage the best software engineers easily.
  • Skedway — Every work experience should be great! Skedway is the complete platform to optimize the hybrid work experience.
Griet Nuytinck Angel
Griet Nuytinck is founder of Anacura.
Show more
Investment focus
  • Medical, Life Science, Biotechnology
  • Seed
  • Belgium
Portfolio highlights
  • 4Tissue — Shaping the Future of Regenerative Medicine
Arman Anatürk Angel · Lausanne, Vaud, Switzerland
Arman Anatürk is Co-Founder @ FoodHack.
Show more
Investment focus
  • Biotechnology, Food and Beverage, Wellness
  • Seed, Pre-Seed
  • Spain, Israel, Germany
Portfolio highlights
  • Bosque Foods — Kinoko Labs develops the next generation of meat substitutes, starting with whole-cut meat items made from fungal mycelium produced organically. Headquartered in New York.
  • Libre Foods — Libre Foods is a biotech startup on a mission to liberate the food system and create a more free future for people, the planet, and animals. The company was founded in 2020 and is based in Barcelona, Catalonia, Spain.
  • Kynda — Keen 4 Greens offers a wide range of vegan products. Founded in 2019, Keen 4 Greens is based in Hamburg, Germany.
Nikolaus Sturm Angel
Nikolaus Sturm
Show more
Investment focus
  • Life Science, Biotechnology
  • Seed
  • Germany
Portfolio highlights
  • DNTOX — We are building up a bioanalytical testing laboratory for animal-free screening of chemicals, regarding their potential to disturb brain development and cause developmental neurotoxicity (DNT). Our in vitro testing battery is based on human cell models and enables chemical screening in a high-content and medium-throughput fashion. Furthermore, itis supported by an in-house developed software, using artifical intelligence. We support our customers during the identification of safe lead structures during substance development, as well as the safety assessment during approval and re-approval processes of chemicals. With our innovation, we want to realize our company vision: Safe chemicals without animal experiments!
Sophia Bendz Angel · Stockholm, Stockholms Lan, Sweden
Sophia Bendz - Partner @ Cherry Ventures
Show more
Investment focus
  • Health Care, Software, Apps
  • Seed, Pre-Seed, Funding Round
  • Sweden, United Kingdom, United States
Portfolio highlights
  • mayk — Mayk sounds. Mayk music. Mayk noise. Mayk it... In an app.
  • Medoma — Medoma is a Swedish virtual ward company that offer patients acute hospital care in their home instead of in the hospital.
  • Wikifarmer — A free online knowledge library where professional or amateur farmers can find best practices on growing their fields more effectively and an online marketplace where farmers can sell their products to buyers directly. Our vision is to create a fair, transparent and profitable environment for all the farming world. Farmers are dedicating theirlives in cultivating their fields, but get the lowest value of all the sales cycle, so we believe they need to receive a more fair share. Buyers have the right to have more options and buy at better prices, so we want to be the ones to solve this inequality in both sides.
Milad Alucozai Angel · San Francisco, California, United States
Dr. Milad Alucozai is an Afghan-American neuroscientist, entrepreneur, biotech executive, and global investor with nearly two decades of experience in deep tech, primarily in life sciences. He pushes the boundaries of bioengineering and computational advancements, integrating machine learning and artificial intelligence into biology and medicine.With a strong commitment to commercializing transformative technologies and fostering startup ecosystems worldwide, he is a thought leader and formal mentor for entrepreneurs through organizations like Creative Destruction Lab and the Wyss Institute at Harvard Medical School.Currently, Milad is the head of Bio and Deep Tech at BoxOne Ventures, where he spearheads the firm’s investments in early-stage companies with breakthrough scientific ideas. With nearly 80 early-stage investments, they are recognized as one of North America’s most active venture firms. He is also a Venture Partner at Entrepreneur First, a global fund that has built over 500 companies from scratch with an enterprise value of $10bn. He supports founders with strategy, scaling, business development, securing growth capital, and leadership training, often being their first investor and guiding them from startup inception to IPOs or acquisitions.He started his career in translational neuroscience and multiphysics laboratories before transitioning into founding roles at biotech startups. He is part of the founding team at Mekonos, a San Francisco-based company creating a proprietary cell-engineering platform to support the future of cell and gene therapies. He was also part of the founding team at Corstem, which specialized in machine learning and artificial intelligence software and was later acquired by Circle Cardiovascular, a platform in over 1000 hospitals and more than 40 countries. At Accenture, Milad directed teams of data scientists, designers, and engineers in developing artificial intelligence platforms for global pharmaceutical companies and hospital networks.Milad serves as a Fellow in Healthcare Engineering at the Regenstrief Center. In 2020, he served as an External Advisor to AstraZeneca. He was recognized as a National Science Foundation Scholar and Macklin Fellow at Johns Hopkins Medicine. He graduated Phi Beta Kappa with a degree in Neuroscience from Purdue University’s Honors Program. As a George J. Mitchell Scholar, he completed his master’s in Immunology and earned his doctorate from the Richard M. Fairbanks School of Public Health.
Show more
Investment focus
  • Biotechnology, Health Care, Medical
  • Seed, Series A, Pre-Seed
  • United States, Canada, United Kingdom
Portfolio highlights
  • Arpeggio Bio — We engineer medicine based not on a single target, but the biological network as a whole.
  • Future Fields — Future Fields Cellular Agriculture: Serum-Free Growth Media Supplements and Recombinant Proteins - Optimized for the Future of Food.
  • Eigen Therapeutics — Eigen Therapeutics is a biotechnology company developing combination therapeutics for cancer. The company is in the research and development of synergistic therapies that improve efficacy while reducing the toxicity of small molecule therapies and immunotherapies, enabling physicians to get access to novel drugs in areas of unmet medical needs.
Per Falholt Angel · Copenhagen, Hovedstaden, Denmark · 2 investments in the past 12 months
A passion and vision for chemistry and biotechnology led Per (born 1958) to Novo A/S, where he started his career as a research chemist. He subsequently held several managerial positions developing products for the detergent industry and rose to Director for Application Technology in the company’s new enzyme development division in 1995.Hemoved to Raleigh, N.C., to head the company’s U.S. application technology unit in 1997, returning to Denmark three years later as Corporate Vice President of the Enzyme Development and Application division. In April 2000, Per merged the Research and Development division into the newly formed Enzyme Business R&D.Per assumed his current position following Novozymes’ demerger from Novo Nordisk in 2000. As chief science officer, he has helped Novozymes develop a unique industrial biotechnology platform which delivers solutions to meet customer needs and support growth.Per holds a M.Sc. in Chemical Engineering from Technical University of Denmark (DTU). Committed to promoting education and research within the sciences, he was appointed Honorary Professor at DTU’s Institute for Systems Biology in 2010 and became Chairman of the Board in 2013. He is also Chairman of the Young Scientists association in Denmark.Per’s current external positions also include Chairman, DTU, board member of DHI Group, board member of ARTs Biologics A/S, and member of the Danish Council for Research Policy.
Show more
Investment focus
  • Biotechnology, Robotics, Life Science
  • Seed, Pre-Seed, Series A
  • Denmark
Portfolio highlights
  • Reshape Biotech — Fully digital microbiology developed by Reshape Biotech
  • Synamics Therapeutics — Synamics Therapeutics uses AI and predictive modeling for precision oncology and improved drug discovery. Our adaptive medicine approach helps prolong drug effectiveness and improves outcomes for patients with intractable cancers. Learn more about Synamics Therapeutics and how we leverage AI for personalized, adaptive cancer therapies.
Arturo Elizondo Angel · San Francisco, California, United States
Arturo Elizondo is CEO of Clara Foods, a sustainable ingredients company making the world’s most comprehensive egg white substitute. Clara leverages advances in fermentation technology to bring an egg white to the table that is completely animal-free, far more sustainable, and free of salmonella without compromising the qualities we know and love.Prior to joining Clara Foods, Arturo worked at the investment bank Credit Suisse, U.S. Department of Agriculture, and under Supreme Court Justice Sonia Sotomayor.
Show more
Investment focus
  • Wellness, Life Science, Biotechnology
  • Seed, Pre-Seed
  • Spain, Switzerland
Portfolio highlights
  • Libre Foods — Libre Foods is a biotech startup on a mission to liberate the food system and create a more free future for people, the planet, and animals. The company was founded in 2020 and is based in Barcelona, Catalonia, Spain.
  • Cultivated Biosciences — Cultivated - Creamy, dairy-free indulgence
Investors by industry
Investors by country
Angel Investors in Europe by industry